SCHEMBL470368

SCHEMBL470368

C/C=C/OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692346 1.00
SCHEMBL503842 1.00
Ethylene Glycol SCHEMBL7774871 0.88 ALDH1A1 (0.33)
Ethylene Glycol SCHEMBL27570078 0.88 ALDH1A1 (0.33)
SCHEMBL10763139 0.82 CASP1 (0.37)
SCHEMBL10763149 0.82 CASP1 (0.37)
Ether SCHEMBL250278 0.82 ALDH1A1 (0.40)
SCHEMBL8052611 0.81
SCHEMBL1407387 0.81
SCHEMBL1407388 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116063625-B Anti-swelling and shrinkage swelling agent, and preparation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-117024646-A Poly (alkylene ether) acid ester compound, and preparation method and application thereof 江西苏克尔新材料有限公司 2023-11-10 CN claimed
CN-116063625-A Anti-swelling and shrinkage swelling agent, and preparation method and application thereof 中国石油化工股份有限公司 2023-05-05 CN claimed
CN-109761761-B Preparation method of ethoxypropylene 山东国邦药业股份有限公司 2022-06-14 CN claimed
CN-114195622-A Method for continuously producing 1-ethoxypropylene 浙江医药股份有限公司新昌制药厂 2022-03-18 CN claimed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 US claimed
US-6979686-B1 Substituted pyrazoles as p38 kinase inhibitors PHARMACIA CORPORATION (US) 2005-12-27 US claimed
US-6525059-B1 Mitogen-activated protein kinases (MAP); G. D. SEARLE & COMPANY 2003-02-25 US claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP claimed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO claimed
EP-0345111-B1 SURFACTANT BASED ON AN OXYETHYLENE AND OXYPROPYLENE PHENYL-1-ETHYL PHENOL, METHOD FOR ITS PREPARATION, ITS USE IN OBTAINING CONCENTRATED SOLUTIONS OF ACTIVE COMPOUNDS RHONE-POULENC GERONAZZO S.p.A. (IT) 1993-07-21 EP claimed
EP-0345111-A2 Surfactant based on an oxyethylene and oxypropylene phenyl-1-ethyl phenol, method for its preparation, its use in obtaining concentrated solutions of active compounds RHONE-POULENC GERONAZZO S.p.A. (IT) 1989-12-06 EP claimed
EP-4720067-A1 BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY Recursion Pharmaceuticals, Inc. (US) 2026-04-08 EP disclosed
US-20260079169-A1 VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION TECHNION RES & DEV FOUNDATION (IL) 2026-03-19 US disclosed
US-20250223225-A1 CONSTRUCTION MATERIAL DRY MIXES CONTAINING SOLID VINYL ESTER RESINS WACKER CHEMIE AG (DE) 2025-07-10 US disclosed
US-4222931-A Stabilizers for synthetic polymers comprising 2,2,6,6-tetramethyl-4-piperidyl ether alcohol or ether, phosphonic acid ester and phenolic antioxidant ARGUS CHEMICAL CORPORATION (US) 1980-09-16 US disclosed
US-4210577-A Stabilizers for synthetic polymers comprising 2,2,6,6-tetramethyl-4-piperidyl carboxylic acid ester, phosphonic acid ester and phenol ARGUS CHEMICAL CORPORATION (US) 1980-07-01 US disclosed
US-3993684-A PHOTOSENSITIVE ACRYLIC ESTER POLYMERS WESTERN LITHO PLATE & SUPPLY CO. (US) 1976-11-23 US disclosed